When Dyspnea Is More Than Pneumonia: Interwoven Mechanisms Of Autoimmune Multiorgan Disease In An Adolescent—A Case Report
DOI:
https://doi.org/10.58344/jii.v4i11.7204Keywords:
Autoimmune disease, dyspnea, nephritis, pulmonary hypertension, anemiaAbstract
Dyspnea in adolescents is often underestimated as a simple respiratory infection, yet it may represent the fairst sign of complex autoimmune multiorgan disease. This report highlights the autoimmune mechanisms underlying dyspnea to promote early recognition of autoimmune disease in adolescents. An 18-year-old female presented with acute worsening of chronic dyspnea. She was tachypneic hypertensive, hypoxemic, and severe anemia. Examination revealed pallor, edema, basal fine crackles, and gallop. Laboratory findings showed renal impairment with proteinuria and hematuria. The albumin was normal and blood gas indicated respiratory alkalosis with compensatory metabolic acidosis. Infectious work-up revealed yeast-like fungi and mixed gram-positive cocci/gram-negative bacilli, while GeneXpert MTB was negative. Chest radiograph demonstrated pulmonary edema with pneumonia. Electrocardiography showed sinus tachycardia 119 bpm with right axis deviation and right ventricular hypertrophy. Echocardiography revealed right atria and ventricle enlargement, moderate tricuspid regurgitation, mild pericardial effusion, intermediate pulmonary hypertension, and preserved EF 64%. ANA test was positive, but performed only at discharge before referral for definitive immunological workup. The patient's life-threatening multiorgan dyspnea could be concluded as four major mechanisms, such as : 1) Renal & Volume Overload; 2) Cardiopulmonary Vasculopathy; 3) Autoimmune and Infectious Pulmonary Damage; 4) Severe Anemia. The profound multiorgan involvement and severe systemic inflammation provided a strong clinical rationale for highly active systemic autoimmune disease (SAID), most probable being Systemic Lupus Erythematosus. This case illustrates how adolescents' dyspnea with complicated systemic symptoms deserves an early diagnosis of autoimmune disease without waiting for infectious exclusion, to prevent the devastating consequences associated with diagnostic latency and delayed targeted intervention. As life-threatening dyspnea in an adolescent may be the catastrophic initial presentation of Probable Systemic Lupus Erythematosus.References
Ardalan, M.-R. (2013) ‘Anemia in lupus nephritis; etiological profile’, Journal of Renal Injury Prevention , 2(3), p. 103.
Aringer, M. et al. (2019) ‘2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus’, Arthritis & Rheumatology, 71(9), pp. 1400–1412.
Bertsias, G.K. et al. (2019) ‘EULAR Recommendations for the Management of Systemic Lupus Erythematosus with Neuropsychiatric Manifestations’, Annals of the Rheumatic Diseases, 78(6), pp. 736–745.
Carrozzo, Marco, Porter, Stephen, Mercadante, Valeria, & Fedele, Stefano. (2019). Oral lichen planus: A disease or a spectrum of tissue reactions? Types, causes, diagnostic algorhythms, prognosis, management strategies. Periodontology 2000, 80*(1), 105–125.
Chen, L.S. et al. (2020) 'Diagnostic Delays in Pediatric Systemic Lupus Erythematosus: A Systematic Review', Seminars in Arthritis and Rheumatism, 50(3), pp. 463–470.
Charras, AMANDINE, Smith, E., & Hedrich, C. M. (2021). Systemic lupus erythematosus in children and young people. Current Rheumatology Reports, 23(3), 20.
Cojocaru, M. et al. (2011) ‘Manifestations of Systemic Lupus Erythematosus’, Mædica, 6(4), p. 330.
Deidda, M. et al. (2023) ‘Right Ventricular Subclinical Dysfunction in SLE Patients Correlates with Metabolomic Fingerprint and Organ Damage’, Metabolites, 13(7), p. 781.
Department of Pediatrics, Sri Ramachandra Institute of Higher Education and Research, Chennai, India et al. (2025) ‘Delayed treatment leading to multisystem complications in a child with SLE’, Revista român? de reumatologie, 34(3), pp. 217–223.
Dhala, A. (2012) ‘Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: Current Status and Future Direction’, Clinical and Developmental Immunology, 2012, p. 854941.
Gagnier, J.J. et al. (2013) 'The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development', Global Advances in Health and Medicine, 2(5), pp. 38–43.
Giannouli, S. et al. (2005) ‘Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment’, Annals of the Rheumatic Diseases, 65(2), p. 144.
Jain, V. et al. (2018) ‘Pulmonary Systemic Lupus Erythematosus Mimicking a Pneumonia in a Postpartum Female’, Case Reports in Rheumatology, 2018, p. 5379192.
Livingston, B. et al. (2019) 'Early Aggressive Disease in Adolescent-onset Systemic Lupus Erythematosus', Lupus Science & Medicine, 6(1), e000334.
Mitchell, J.L. (2024) ‘Understanding the impact of delayed diagnosis and misdiagnosis of systemic lupus erythematosus (SLE)’, Journal of Family Medicine and Primary Care, 13(11), p. 4819.
Ostrov, B.E. (2023) ‘Reliability and reproducibility of antinuclear antibody testing in pediatric rheumatology practice’, Frontiers in Medicine, 9, p. 1071115.
Parperis, K. et al. (2023) ‘Systemic Lupus Erythematosus and Pulmonary Hypertension’, International Journal of Molecular Sciences, 24(6), p. 5085.
Pennesi, M. and Benvenuto, S. (2023) Lupus Nephritis in Children: Novel Perspectives. Medicina, 59(10), p.1841.
Rosenkranz, S. et al. (2020) ‘Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure’, Circulation [Preprint]. Available at: [https://doi.org/10.1161/Circulationaha.116.022362](https://doi.org/10.1161/Circulationaha.116.022362).
Stinson, J.N. et al. (2018) 'Prevalence and Characteristics of Chronic Dyspnea in Adolescents: A Cross-Sectional Study', Pediatric Pulmonology, 53(7), pp. 921–928.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Karina Cahya Widati

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.





